PMS-Loperamide · DIN 02228351 · 2 mg · Caplet
Limited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 required
Write on scriptone applicable Reason for Use code, 110 or 111 or 112 or 113 or 114 or 115 or 224 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 110, 111, 112, 113, 114, 115, 224
Coverage limit:
For the treatment of diarrhea associated with:
Reason for Use code 110
An ileostomy or a colostomy;.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 111
Bowel resection, including short bowel syndrome;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 112
Inflammatory Bowel Diseases, i.e. Crohn's Disease and Ulcerative Colitis;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 113
Cancer, including chemotherapy or radiation therapy;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 114
HIV/AIDS;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 115
Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 224
Fecal incontinence.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
PMS-Loperamide · DIN 02228351
Manufacturer: Pharmascience Inc.; listing date 1998-12-31
Health Canada: Marketed since 1996-09-12 · brand PMS-LOPERAMIDE - CAPLET 2MG · ATC A07DA03 LOPERAMIDE · form Tablet · route Oral · ingredients LOPERAMIDE HYDROCHLORIDE 2 MG · company Pharmascience inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordPMS-Loperamide: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.0952). What the ministry pays, not the patient.
Ministry pays: $0.0952 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02228351)
Source record
DIN 02228351: PMS-Loperamide
Raw flags: sec12=Y, sec3=Y
Item: 560800015; group id 647; item number 1626; lccId 00096; manufacturer id PMS
Source form: Caplet; strength: 2mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.0952; ministry $0.0952
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02228351
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43486
Interchangeable products
Apo-Loperamide · DIN 02212005 · $0.0952
Imodium · DIN 00860743 · not recorded
Teva-Loperamide · DIN 02132591 · $0.0952
Shortage status: resolved shortage (ended February 6, 2019); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02228351
Shortage record checked October 6, 2026
Teva-Loperamide · DIN 02132591 · 2 mg · Caplet
Limited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 required
Write on scriptone applicable Reason for Use code, 110 or 111 or 112 or 113 or 114 or 115 or 224 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 110, 111, 112, 113, 114, 115, 224
Coverage limit:
For the treatment of diarrhea associated with:
Reason for Use code 110
An ileostomy or a colostomy;.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 111
Bowel resection, including short bowel syndrome;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 112
Inflammatory Bowel Diseases, i.e. Crohn's Disease and Ulcerative Colitis;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 113
Cancer, including chemotherapy or radiation therapy;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 114
HIV/AIDS;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 115
Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 224
Fecal incontinence.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Teva-Loperamide · DIN 02132591
Manufacturer: Teva Canada Limited; listing date 1997-08-28
Health Canada: Marketed since 2016-12-23 · brand TEVA-LOPERAMIDE · ATC A07DA03 LOPERAMIDE · form Tablet · route Oral · ingredients LOPERAMIDE HYDROCHLORIDE 2 MG · company Teva canada limited · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Loperamide: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.0952). What the ministry pays, not the patient.
Ministry pays: $0.0952 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02132591)
Source record
DIN 02132591: Teva-Loperamide
Raw flags: sec12=Y, sec3=Y
Item: 560800015; group id 647; item number 1626; lccId 00096; manufacturer id TEV
Source form: Caplet; strength: 2mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.0952; ministry $0.0952
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02132591
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18071
Interchangeable products
Apo-Loperamide · DIN 02212005 · $0.0952
Imodium · DIN 00860743 · not recorded
PMS-Loperamide · DIN 02228351 · $0.0952
Shortage status: resolved shortage (ended July 20, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02132591
Shortage record checked October 6, 2026
Apo-Loperamide · DIN 02212005 · 2 mg · Caplet
Limited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 requiredDormant since August 4, 2017 · checked October 5, 2026 · What does dormant mean? StatusLimited Use, Reason for Use code 110, 111, 112, 113, 114, 115, 224 required
Write on scriptone applicable Reason for Use code, 110 or 111 or 112 or 113 or 114 or 115 or 224 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 110, 111, 112, 113, 114, 115, 224
Coverage limit:
For the treatment of diarrhea associated with:
Reason for Use code 110
An ileostomy or a colostomy;.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 111
Bowel resection, including short bowel syndrome;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 112
Inflammatory Bowel Diseases, i.e. Crohn's Disease and Ulcerative Colitis;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 113
Cancer, including chemotherapy or radiation therapy;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 114
HIV/AIDS;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 115
Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 224
Fecal incontinence.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Apo-Loperamide · DIN 02212005
Manufacturer: Apotex Inc.; listing date 1996-12-19
Health Canada: Dormant since 2017-08-04 · brand APO-LOPERAMIDE · ATC A07DA03 LOPERAMIDE · form Tablet · route Oral · ingredients LOPERAMIDE HYDROCHLORIDE 2 MG · company Apotex inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Loperamide: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.0952). What the ministry pays, not the patient.
Ministry pays: $0.0952 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02212005)
Source record
DIN 02212005: Apo-Loperamide
Raw flags: sec12=Y, sec3=Y
Item: 560800015; group id 647; item number 1626; lccId 00096; manufacturer id APX
Source form: Caplet; strength: 2mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.0952; ministry $0.0952
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02212005
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=20012
Interchangeable products
Imodium · DIN 00860743 · not recorded
PMS-Loperamide · DIN 02228351 · $0.0952
Teva-Loperamide · DIN 02132591 · $0.0952
Shortage status: active shortage (reported October 9, 2014, last updated October 5, 2017) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02212005
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 4, 2017 — choose a marketed DIN from the same-category list.
Imodium · DIN 00860743 · 2 mg · Caplet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 1999-06-16 — choose a marketed DIN from the same-category list.Discontinued June 16, 1999 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 1999-06-16 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 1999-06-16 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 110, 111, 112, 113, 114, 115, 224
Coverage limit:
For the treatment of diarrhea associated with:
Reason for Use code 110
An ileostomy or a colostomy;.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 111
Bowel resection, including short bowel syndrome;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 112
Inflammatory Bowel Diseases, i.e. Crohn's Disease and Ulcerative Colitis;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 113
Cancer, including chemotherapy or radiation therapy;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 114
HIV/AIDS;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 115
Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 224
Fecal incontinence.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Imodium · DIN 00860743
Manufacturer: Janssen Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 1999-06-16 · brand IMODIUM CAPLETS 2MG · ATC A07DA03 LOPERAMIDE · form Tablet · route Oral · ingredients LOPERAMIDE HYDROCHLORIDE 2 MG/TAB · company Janssen pharmaceutica, division of janssen-ortho inc. · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordImodium: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00860743)
Source record
DIN 00860743: Imodium
Raw flags: notABenefit=Y, sec3=Y
Item: 560800015; group id 647; item number 1626; lccId 00096; manufacturer id JAN
Source form: Caplet; strength: 2mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00860743
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10543
Interchangeable products
Apo-Loperamide · DIN 02212005 · $0.0952
PMS-Loperamide · DIN 02228351 · $0.0952
Teva-Loperamide · DIN 02132591 · $0.0952
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00860743
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since June 16, 1999 — choose a marketed DIN from the same-category list.